Jump to section
To replicate human tissue at scale so that researchers and doctors can provide patients with better clinical treatments.
Cellbricks is at the forefront of addressing a critical challenge in modern medicine: the scarcity of donor organs and tissues for transplantation. With the global demand for organ transplants continually on the rise, the company stands as a biotech leader that combines world-leading expertise in synthetic biology and 3D printing.
Leveraging proprietary biofabrication technology and tissue engineering proficiency, Cellbricks allows for the scalable replication of human tissue. This breakthrough has immense potential to transform clinical treatments, enabling researchers and doctors to provide patients with more effective and accessible solutions.
The team at Cellbricks is working towards a future where the biofabrication of organs and human tissue becomes standard medical practice. This vision aligns with the broader goal of helping humanity enjoy longer, healthier lives, and makes the company one to watch in the ever-evolving field of advanced healthcare.
Freddie
Company Specialist at Welcome to the Jungle
Lutz Kloke
(Founder)Previously a Research Scientist at Deutsches Rheuma-Forschungszentrum.